FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3470811000001103: Prempak-C 0.625mg tablets (Wyeth Laboratories) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17325901000001117 Prempak-C 0.625mg tablets (Wyeth Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
73232301000001118 Prempak-C 0.625mg/0.15mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Is a Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has excipient Lactose false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has active ingredient Estrogen false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Is a Prempak-C true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has active ingredient Conjugated estrogen false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has active ingredient Norgestrel false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) Has excipient Beeswax false Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Prempak-C 0.625mg tablets (Wyeth Laboratories) 120 tablet 3 x (28 tablets + 12 tablets) Is pack of False Prempak-C 0.625mg tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier
Prempak-C 0.625mg tablets (Wyeth Laboratories) 120 tablet 3 x (28 tablets + 12 tablets) Has AMP True Prempak-C 0.625mg tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start